Mainz Enterprise Value Over E B I T D A from 2010 to 2024

MYNZ Stock  USD 7.32  0.40  5.78%   
Mainz Biomed Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA will likely drop to -0.81 in 2024. During the period from 2010 to 2024, Mainz Biomed Enterprise Value Over EBITDA regression line of annual values had significance of  0 and arithmetic mean of (129.15). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(0.77)
Current Value
(0.81)
Quarterly Volatility
80.3077064
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Mainz Biomed BV over the last few years. It is Mainz Biomed's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Mainz Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(129.15)
Coefficient Of Variation(62.18)
Mean Deviation67.41
Median(169.77)
Standard Deviation80.31
Sample Variance6,449
Range228
R-Value0.70
Mean Square Error3,566
R-Squared0.49
Significance0
Slope12.53
Total Sum of Squares90,291

Mainz Enterprise Value Over E B I T D A History

2024 -0.81
2023 -0.77
2022 -3.37
2021 -6.1
2020 -228.51

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(0.77)(0.81)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.